- Plans tax-free separation into two distinct healthcare companies targeted for H1 2028
- Separation creates dedicated retail pharmacy vs. health solutions/benefits entities
- CVS concurrently raised its full-year 2026 financial guidance
Live T0 archive · $CVS · Filing
$CVS SEC Filing Alert & Real-Time AI Stock Impact Analysis
T0 SEO archive for $CVS: filings appear instantly. AI score, direction and bullet analysis unlock publicly after 4 hours (VIP sees them live).
Bullish AI Sentiment (+6.5 / 10)
Observed market reaction after signal
Peak +2.26%
Bullish AI Sentiment (+6.5 / 10)
- Q3 revenue increased 5.4% YoY to $108.4 billion; GAAP diluted EPS swung to $1.68 from -$3.13.
- Q3 adjusted diluted EPS reached $2.09 vs. $1.60 in the prior-year quarter.
- Full-year 2026 Adjusted EPS guidance raised to at least $8.20 (prior range: $7.90 to $8.10).
Observed market reaction after signal
Peak +2.26%